SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-012623 to Allakos Inc. (ALLK) (CIK 0001564824)

Allakos Inc. (ALLK) (CIK 0001564824)
Date: Nov. 17, 2023 · CIK: 0001564824 · Accession: 0000000000-23-012623

AI Filing Summary & Sentiment

File numbers found in text: 333-275517

Date
November 17, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Allakos Inc. (ALLK) (CIK 0001564824)

Letter

United States securities and exchange commission logo November 17, 2023 Baird Radford CFO Allakos Inc. 825 Industrial Road, Suite 500 San Carlos, CA 94070 Re:Allakos Inc. Registration Statement on Form S-3 Filed November 13, 2023 File No. 333-275517 Dear Baird Radford: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Knapp

Show Raw Text
United States securities and exchange commission logo
November 17, 2023
Baird Radford
CFO
Allakos Inc.
825 Industrial Road, Suite 500
San Carlos, CA 94070
Re:Allakos Inc.
Registration Statement on Form S-3
Filed November 13, 2023
File No. 333-275517
Dear Baird Radford:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Jennifer Knapp